For the downstream signaling molecules Btk and PLCγ2 and their phosphorylation sites Btk(Y223) and PLCγ2(Y759), we found similar expression and phosphorylation levels among all patients and HD (Figures 1D,E). This evidence concerns the gene PLCG2 and Huntington disease.